-- 周三盘前，美国股指期货走高，此前美国总统特朗普延长了与伊朗的停火协议，但同时维持了美国对伊朗港口的封锁。 道琼斯工业平均指数期货上涨0.6%，标普500指数期货上涨0.5%，纳斯达克指数期货上涨0.7%。 据特朗普在Truth Social社交媒体平台上发布的消息，他表示伊朗政府“严重分裂”，并称他将延长停火协议，“直到伊朗领导人和代表能够提出统一的方案为止”。 伊朗常驻联合国代表阿米尔-赛义德·伊拉瓦尼表示，一旦美国解除海上封锁，伊朗准备重启和平谈判。伊朗国家通讯社塔斯尼姆周三早间援引鲁达夫通讯社的报道称。 交易员们消化了最新一轮的财报，菲利普莫里斯国际公司（PM）和Vertiv公司（VRT）公布的第一季度调整后盈利和营收均有所增长。与此同时，尽管运营收入增长，但AT&T (T) 公布的第一季度盈利却有所下降。特斯拉 (TSLA) 和 IBM (IBM) 将于盘后公布业绩。 油价上涨，近月全球基准北海布伦特原油上涨1%，至每桶99.46美元；美国西德克萨斯中质原油上涨0.9%，至每桶90.47美元。 亚特兰大联储4月份商业通胀预期调查将于美国东部时间上午10点发布。
Related Articles
Asia
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
$ASX:NAB
Asia
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
$ASX:CUV
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF